Prognostic value of modified Lauren classification in gastric cancer

doi:10.4251/wjgo.v13.i9.1184

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3960)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

186

WORD

111

HTML

2123

Tables (1-3)

153

Sum=2573

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

459

Download

923

Sum=1382

Sep 15, 2021 (publication date) through May 10, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1184-1195
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1184

Table 2 Univariate and multivariable analyses of prognostic factors for overall survival

Variable	No. of patients (%)	Univariate analysis		Multivariate analysis
Variable	No. of patients (%)	5-yr OS	P value	HR (95%CI)	P value
Gender (%)			0.111
Male	1588 (58.4)	45.9%
Female	1130 (41.6)	49.1%
Age (%)			< 0.001		< 0.001
< 60 yr	1217 (44.8)	50.7%		1 (Ref)	–
≥ 60 yr	1501 (55.2)	44.4%		1.157 (1.360–1.692)	< 0.001
Tumor size (%)			< 0.001		0.001
≤ 4.0 cm	1200 (44.2)	63.9%		1 (Ref)	–
> 4.0 cm	1302 (47.9)	33.6%		1.179 (1.038–1.339)	0.011
Unknown	216 (7.9)	40.2%		1.457 (1.191–1.782)	< 0.001
Retrieved lymph nodes (%)			0.074		< 0.001
Adequate (n ≥ 16)	1418 (52.2)	48.9%		1 (Ref)	–
Inadequate (n < 16)	1300 (47.8)	45.5%		1.550 (1.380–1.740)	< 0.001
AJCC 8^thpT stage (%)			< 0.001		< 0.001
pT1	690 (25.4)	80.9%		1 (Ref)	–
pT2	329 (12.1)	66.6%		1.535 (1.193–1.975)	0.001
pT3	820 (30.2)	38.5%		2.882 (2.334–3.558)	< 0.001
pT4a	670 (24.7)	23.4%		3.415 (2.740–4.256)	< 0.001
pT4b	209 (7.7)	18.6%		4.452 (3.458–5.732)	< 0.001
AJCC 8^thpN stage (%)			< 0.001		< 0.001
pN0	1031 (37.9)	71.6%		1 (Ref)	–
pN1	456 (16.8)	46.9%		1.467 (1.225–1.757)	< 0.001
pN2	507 (18.7)	37.5%		1.611 (1.353–1.919)	< 0.001
pN3a	512 (18.8)	24.8%		2.356 (1.976–2.809)	< 0.001
pN3b	212 (7.8)	9.2%		4.138 (3.306–5.181)	< 0.001
Differentiation grade (%)			0.011		0.135
Well differentiation	95 (3.5)	69.4%		1 (Ref)	–
Moderate differentiation	483 (17.8)	58.9%		0.974 (0.649–1.462)	0.898
Poor differentiation	2054 (75.5)	44.0%		1.123 (0.755–1.670)	0.566
Undifferentiation	86 (3.2)	35.6%		1.415 (0.876–2.285)	0.156
Modified Lauren classification (%)			< 0.001		0.013
Distal non-diffuse type	654 (24.1)	58.8%		1 (Ref)	–
Proximal non-diffuse type	463 (17.0)	48.3%		1.230 (1.033–1.466)	0.020
Diffuse type	1601 (58.9)	42.4%		1.246 (1.068–1.452)	0.005

AJCC: American Joint Committee on Cancer; HR: Hazard ratio; OS: Overall survival; pN stage: Pathological N stage; pT stage: Pathological T stage. Variables with P values less than 0.1 were included in the multivariate analysis.

Citation: Ning FL, Zhang NN, Wang J, Jin YF, Quan HG, Pei JP, Zhao Y, Zeng XT, Abe M, Zhang CD. Prognostic value of modified Lauren classification in gastric cancer. World J Gastrointest Oncol 2021; 13(9): 1184-1195
URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1184.htm
DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.1184